Paragraph 2: Chief Executive Officer

1° The Director General of the Agency is appointed for a renewable term of three years, on the recommendation of the Minister for Health.

He is responsible for managing the Agency. He performs all acts that are not reserved to the Board of Directors by virtue of the provisions of article R. 1418-13.

Each year, it proposes to the Board of Directors the general guidelines of the Agency's policy.

It prepares and implements the decisions of the Board of Directors.

He has authority over all the agency's staff; he recruits, appoints and manages contract staff in accordance with the list of posts drawn up by the Board of Directors.

He represents the agency in legal proceedings and in all civil acts. He enters into contracts, public procurement contracts, acquisitions, sales and transactions on behalf of the agency, subject to the powers conferred on the Board of Directors by the provisions of 5° and 6° of article R. 1418-13.

It is the authorising officer for the Agency's revenue and expenditure. He may appoint secondary authorising officers.

The Director General may delegate his signature to those of his staff who exercise a management function within the Agency;

2° The Managing Director submits the Agency's annual report to the Board of Directors.

This report includes in particular

a) A report on organ, tissue and cell retrieval and transplantation activities, medically assisted procreation, prenatal diagnosis and pre-implantation diagnosis, embryology and medical genetics;

b) An analysis of the authorisations and approvals issued under Article L. 1418-1 ;

c) An assessment of the state of progress of embryo and stem cell research;

d) An assessment of any trafficking in organs or gametes and measures to combat such trafficking;

e) An assessment of the conditions under which the provisions of Article L. 2131-4-1 have been implemented and whether they should be maintained;

f) A financial report and information enabling the performance of the establishment to be assessed.

The annual summary of the work of the Agency's Steering Committee is attached to this report.

The annual report and the opinions and recommendations of the Agency mentioned in the last paragraph of Article L. 1418-3 and falling within their remit are sent to the Ministers for Health, Research and the other Ministers concerned.